- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04408196
QoL and the Emotional-affective Sphere in Rehabilitation Setting During COVID-19 Quarantine
Effects of Social Distancing on the Quality of Life and on the Emotional-affective Sphere of Caregivers and Patients Hospitalized in Residential Rehabilitation Departments: an Observational Study.
Coronavirus disease (COVID-19) is caused by the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) virus. This virus was identified in December 2019 in the Chinese city of Wuhan, in the province of Hubei, where it determined a state of health emergency proclaimed by China on January 30, 2020.
Since February 2020, Italy has been involved in the emergency of the COVID-19 infection, with devastating consequences for the health of the population and the economy of our country. As published by the Italian National Institute of Health, the starting date of the symptoms dates back to the end of January, the first case diagnosed dates back to 21 February 2020 while the first cases of home isolation date back to March 1st, 2020. On March 30, 2020, there were 101739 positive subjects and 11591 deaths (Civil Protection data).
According to data published by the World Health Organization, most people with COVID-19 develop a flu-like form, 14% develop a severe form that requires hospitalization and oxygen therapy and 5% require an ICU admission.
The emergency from Covid19 made it necessary to provide institutional social distancing conditions which resulted in rehabilitation departments being prohibited from visiting patients by family members and/or caregivers. This event, although necessary, led to the first moment of discomfort on the part of patients and family members; to overcome this reaction "technological" solutions were found, trying to give continuity to the contact between the patient and the family member through the use of video calls. Despite this, the COVID-19 emergency and the limitations resulting from social distancing likely have an impact on both patients and family members/caregivers that needs to be assessed.
Study Overview
Status
Conditions
Detailed Description
Aims:
The study aims to measure the quality of life (QoL) and the emotional-affective sphere of patients, currently hospitalized in residential structures, and their family members.
The study data will allow identifying (a) whether the social distancing between family members/caregivers and patients undergoing rehabilitation for orthopedic or neurological disabilities affects the quality of life and the emotional-affective sphere and (b) if these conditions change over time. The data obtained will, therefore, allow identifying those subjects who present a particular fragility of the emotional-affective sphere and who therefore need attention and possibly psychological support that will be prescribed.
Procedures:
Demographic (for patients and caregivers) and anamnestic (only for patients) data will be collected; moreover, disability will be assessed in patients using the modified Barthel index.
Three questionnaires will be administered to patients and caregivers:
- The Short Form (36) Health Survey (SF36), to evaluate the QoL;
- The Beck Anxiety Inventory (BAI), to evaluate the emotional state;
- The Beck Depression Inventory-II (BDI-II), to evaluate mood.
These questionnaires will be administered after one month of hospitalization (T0), and after one (T1) and two (T2) months after T0. Finally, at time T1 and T2 it will be registered if the patient is still hospitalized or discharged (and in the latter case the days between the discharge and the compilation of the questionnaire will be recorded). Since the three selected questionnaires provide for self-administration, to simplify the collection of data relating to caregivers, the implementation and use of an online questionnaire will be assessed. This questionnaire will also provide for the collection of consent to the use of data by the subject and will guarantee their privacy.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Rome, Italy, 00168
- Don Gnocchi Foundation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients admitted to inpatients rehabilitation centers
Caregivers of patients admitted to inpatients rehabilitation centers
Description
Inclusion Criteria:
- patients admitted to the centers of the Don Gnocchi Foundation participating in the study and their caregivers will be recruited
Exclusion Criteria:
- For patients: a score on the Mini-Mental State Examination (MMSE) scale lower than 24 which prevents the administration of SF36;
- For patients and caregivers: failure to acquire informed consent
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
Patients
100 patients admitted to an inpatient rehabilitation facility
|
Caregivers
100 caregivers of patients admitted to an inpatient rehabilitation facility
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Short Form-36 Health Survey (SF36)
Time Frame: After one month of hospitalisation (baseline, T0)
|
It is a questionnaire to evaluate the Quality of Life
|
After one month of hospitalisation (baseline, T0)
|
Short Form (36) Health Survey (SF36)
Time Frame: One month after baseline (T1)
|
It is a questionnaire to evaluate the Quality of Life
|
One month after baseline (T1)
|
Short Form (36) Health Survey (SF36)
Time Frame: Two months after baseline (T2)
|
It is a questionnaire to evaluate the Quality of Life
|
Two months after baseline (T2)
|
Beck Anxiety Inventory (BAI)
Time Frame: After one month of hospitalisation (baseline,T0)
|
It is a brief, criteria-referenced assessment for measuring anxiety severity and level
|
After one month of hospitalisation (baseline,T0)
|
Beck Anxiety Inventory (BAI)
Time Frame: One month after baseline (T1)
|
It is a brief, criteria-referenced assessment for measuring anxiety severity and level
|
One month after baseline (T1)
|
Beck Anxiety Inventory (BAI)
Time Frame: Two months after baseline (T2)
|
It is a brief, criteria-referenced assessment for measuring anxiety severity and level
|
Two months after baseline (T2)
|
Beck Depression Inventory-II (BDI-II)
Time Frame: After one month of hospitalisation (baseline)
|
It is a brief, criteria-referenced assessment for measuring depression severity
|
After one month of hospitalisation (baseline)
|
Beck Depression Inventory-II (BDI-II)
Time Frame: One month after baseline (T1)
|
It is a brief, criteria-referenced assessment for measuring depression severity
|
One month after baseline (T1)
|
Beck Depression Inventory-II (BDI-II)
Time Frame: Two months after baseline (T2)
|
It is a brief, criteria-referenced assessment for measuring depression severity
|
Two months after baseline (T2)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
modified Barthel Index (mBI)
Time Frame: After one month of hospitalisation (baseline, T0)
|
It is a measure of physical disability used widely to assess behaviour relating to activities of daily living for stroke patients or patients with other disabling conditions.
|
After one month of hospitalisation (baseline, T0)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Irene APRILE, MD,PHD, IRCCS Fondazione Don Carlo Gnocchi
Publications and helpful links
General Publications
- Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol. 1998 Nov;51(11):1025-36. doi: 10.1016/s0895-4356(98)00094-8.
- Aprile I, Piazzini DB, Bertolini C, Caliandro P, Pazzaglia C, Tonali P, Padua L. Predictive variables on disability and quality of life in stroke outpatients undergoing rehabilitation. Neurol Sci. 2006 Apr;27(1):40-6. doi: 10.1007/s10072-006-0563-5.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- FDG_socialdistancing_COVID-19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rehabilitation
-
Westfälische Wilhelms-Universität MünsterNational Paralympic Committee Germany (NPCG)CompletedCardiac Rehabilitation | Feasibility Studies | Organization and Administration | Rehabilitation ExerciseGermany
-
Asan Medical CenterRecruitingPulmonary Rehabilitation | Cardiac RehabilitationKorea, Republic of
-
University Hospital, ToursCompletedPulmonary Rehabilitation | Respiratory RehabilitationFrance
-
Suleyman Demirel UniversityCompleted
-
Orton Orthopaedic HospitalCompleted
-
Richard Watson, PTCompletedMedial Patellar Femoral Ligament Reconstruction Rehabilitation | Anterior Cruciate Ligament Reconstruction RehabilitationUnited States
-
Cairo UniversityRecruiting
-
Bruyere Research InstituteBruyere Academic Medical OrganizationRecruiting
-
National Cheng Kung UniversityRecruiting
-
University College AbsalonUniversity of Southern Denmark; Arla Foods; Danish Council for Independent Research and other collaboratorsCompleted